We are live on ! Find out more
XERS icon

Xeris Biopharma Holdings
XERS

144 hedge funds and large institutions have $182M invested in Xeris Biopharma Holdings in 2024 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 34 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

271% more call options, than puts

Call options by funds: $1.26M | Put options by funds: $340K

79% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 14

41% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 34

33% more capital invested

Capital invested by funds: $136M → $182M (+$45.7M)

7% more funds holding

Funds holding: 134 → 144 (+10)

1.99% more ownership

Funds ownership: 40.91% → 42.9% (+2%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
144
Holders Change
+10
Holders Change %
+7.46%
% of All Funds
2.07%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
25
Increased
48
Reduced
34
Closed
14
Calls
$1.26M
Puts
$340K
Net Calls
+$922K
Net Calls Change
+$192K

Top Buyers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
+$5.61M
2
CP
CenterBook Partners
Connecticut
+$5.18M
3
Walleye Capital
Walleye Capital
New York
+$2.88M
4
Morgan Stanley
Morgan Stanley
New York
+$1.91M
5
KCM
Kennedy Capital Management
Missouri
+$1.55M

Top Sellers

Rank Fund Capital Flow
1
MB
MPM BioImpact
Massachusetts
-$10.9M
2
GCP
GSA Capital Partners
United Kingdom
-$1.49M
3
ICM
Invenomic Capital Management
Massachusetts
-$1.33M
4
Lazard Asset Management
Lazard Asset Management
New York
-$662K
5
Millennium Management
Millennium Management
New York
-$644K
Name Holding Trade Value Shares
Change 		Change in
Stake
GRP
126
Global Retirement Partners
California
$3.17K +$1.8K +700 +169%
PMAM
127
Picton Mahoney Asset Management
Ontario, Canada
$3K +$2.61K +1,015 New
AWM
128
Activest Wealth Management
Florida
$2.85K – – –
TWD
129
True Wealth Design
Ohio
$2.61K +$2.35K +916 New
SWC
130
Spectrum Wealth Counsel
Indiana
$2.38K +$2.14K +834 New
Nisa Investment Advisors
131
Nisa Investment Advisors
Missouri
$2.05K +$873 +340 +90%
TFGT
132
TS Financial Group (TSFG)
Illinois
$2K – – –
Comerica Bank
133
Comerica Bank
Texas
$1.74K +$1.57K +611 New
Allspring Global Investments
134
Allspring Global Investments
North Carolina
$1.73K -$40.3K -15,675 -96%
EWA
135
EverSource Wealth Advisors
Alabama
$1.33K – – –
Daiwa Securities Group
136
Daiwa Securities Group
Japan
$1K – – –
RIL
137
Rothschild Investment LLC
Illinois
$599 +$218 +85 +68%
IA
138
IFP Advisors
Florida
$570 – – –
FFA
139
Farther Finance Advisors
California
$516 +$18 +7 +4%
Federated Hermes
140
Federated Hermes
Pennsylvania
$516 +$465 +181 New
SCM
141
Sterling Capital Management
North Carolina
$405 +$365 +142 New
ACA
142
American Capital Advisory
Idaho
$143 +$128 +50 New
WSFS
143
Wilmington Savings Fund Society
Delaware
$114 +$103 +40 New
DB
144
Danske Bank
Denmark
$6 +$5 +2 New
MB
145
MPM BioImpact
Massachusetts
– -$10.9M -4,830,526 Closed
ICM
146
Invenomic Capital Management
Massachusetts
– -$1.33M -592,078 Closed
Cetera Investment Advisers
147
Cetera Investment Advisers
Illinois
– -$266K -118,443 Closed
SCM
148
Soleus Capital Management
Connecticut
– -$140K -62,083 Closed
Dimensional Fund Advisors
149
Dimensional Fund Advisors
Texas
– -$109K -48,663 Closed
SA
150
Sanctuary Advisors
Indiana
– -$58.5K -33,429 Closed
3 4 5
6
7

XERS Hedge Fund Activity: Q3 2024 in Review

144 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Xeris Biopharma Holdings (XERS) for Q3 2024, worth a combined $182M — up 33% from $136M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new XERS positions and 14 closed out — a net gain of 11 holders — while 48 added to existing stakes and 34 trimmed.

The largest buyer was AIGH Capital Management, opening a new position worth an estimated $5.61M. The largest seller was MPM BioImpact, exiting entirely with an estimated $10.9M sold.

  • 144 institutional investors held Xeris Biopharma Holdings (XERS) as of Q3 2024, up from 134 in Q2 2024.
  • Funds reported $182M of Xeris Biopharma Holdings stock for Q3 2024, up 33% quarter-over-quarter.
  • 25 funds opened new Xeris Biopharma Holdings positions in Q3 2024 and 14 closed out, a net change of +11 holders.
  • The largest Xeris Biopharma Holdings buyer in Q3 2024 was AIGH Capital Management, an estimated $5.61M added.
  • The largest Xeris Biopharma Holdings seller in Q3 2024 was MPM BioImpact, an estimated $10.9M sold.

Based on aggregated 13F filings for Q3 2024.